Figure 5 (IMAGE)

Impact Journals LLC

Figure 5

Caption

Figure 5: TAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling.

Credit

2024 Zhang et al.

Usage Restrictions

Original Content

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.